It was a really interesting call – with LOTS of great questions from the participants. Thanks to everyone who made it so dynamic – including presenter Ian McGowan and all the folks who asked really important questions.
In this call, Ian McGowan, co-principal investigator of the Microbicide Trials Network and Principal Investigator of CHARM (the Combination HIV Antiretroviral Rectal Microbicide Program) provided an update on what is happening with this innovative program.
Funded by the U.S. National Institutes of Health in 2009, CHARM is an $11 million, five year, multicenter grant intended to advance candidate rectal microbicides from discovery into early clinical development. Rather than simply testing existing vaginal formulations of microbicides, CHARM seeks to develop rectal-specific products from the beginning.
Did you know we save ALL the slides and recordings from all of our teleconferences? Click IRMA’s teleconference page to peruse previous call materials…
*Join IRMA’s robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us at firstname.lastname@example.org. Joining our listserv automatically makes you a member of IRMA – a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.
*Please look for us on Facebook: www.facebook.com/InternationalRectalMicrobicideAdvocates, and you can follow us on Twitter: @rectalmicro.
*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article’s content.